HarMono-T 5 microlitres/mL gas and solvent for dispersion for injection/infusion
CTSP-001
Phase 2 small_molecule active
Quick answer
HarMono-T 5 microlitres/mL gas and solvent for dispersion for injection/infusion for Ultrasound contrast agent, for diagnostic purposes (to assess indeterminate kidney lesions) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Ultrasound contrast agent, for diagnostic purposes (to assess indeterminate kidney lesions)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active